Cochlear (COH) AGM 2024 summary
Event summary combining transcript, slides, and related documents.
AGM 2024 summary
18 Jan, 2026Opening remarks and agenda
The meeting was opened by the Chair, acknowledging traditional custodians and welcoming shareholders both in person and online.
Meeting procedures, voting, and Q&A protocols were outlined, with polling open throughout and results to be released to the ASX.
Financial performance review
Achieved record sales revenue of AUD 2.3 billion, up 12% in constant currency, and underlying net profit of AUD 387 million, up 15% in constant currency.
Dividends increased by 24%, with a payout ratio of 69% of underlying net profit.
Net cash exceeded AUD 500 million, supporting investments and capital expenditure.
FY25 guidance targets underlying net profit growth of 6–11%.
Board and executive committee updates
Board renewal continued, with Caroline Clarke appointed and Yasmin Allen retiring.
Female representation on the board rose to 44%.
Directors standing for re-election included Alison Deans, Glen Boreham, and Christine McLoughlin; Caroline Clarke stood for election.
Latest events from Cochlear
- Underlying net profit dropped 9% despite 1% revenue growth, with a stronger second half expected.COH
H1 202611 Jun 2026 - Net profit rose 9% to $389M on 4% revenue growth, with FY26 profit set to rise 11–17%.COH
H2 20255 Jun 2026 - HY25 sales and profit rose, but Services revenue fell; FY25 outlook cautious on cloud spend.COH
H1 20255 Jun 2026 - Underlying net profit rose 27% on 15% revenue growth, with robust FY25 outlook.COH
H2 20245 Jun 2026 - Profit outlook cut to $290-330 million amid weak demand and global disruptions.COH
Trading update15 May 2026 - Sales, profit, and dividends rose; R&D, board renewal, and global growth remain priorities.COH
AGM 202523 Oct 2025